Paul Tam
Overview
Explore the profile of Paul Tam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taskapan H, Mahdavi S, Bellasi A, Martin S, Kuvadia S, Patel A, et al.
Clin Kidney J
. 2024 Jul;
17(7):sfae188.
PMID: 39070948
Background: Fibroblast growth factor 23 (FGF-23) and other markers of chronic kidney disease-mineral and bone disorder (CKD-MBD) provide valuable insights into disease processes, treatment options and patient prognosis. However, limited...
2.
Sikaneta T, Ho N, Bellasi A, Mahdavi S, Taskapan H, Svendrovski A, et al.
Cardiorenal Med
. 2023 Nov;
14(1):45-57.
PMID: 37963445
Introduction: QTc interval prolongation is increasingly frequent as chronic kidney disease (CKD) advances and predicts death in dialysis. However, predictors and mortality risk in predialysis CKD are understudied. FGF23 induces...
3.
Yau K, Tam P, Chan C, Hu Q, Qi F, Abe K, et al.
Clin J Am Soc Nephrol
. 2023 Oct;
19(1):85-97.
PMID: 37847518
Background: There is a lack of randomized controlled trial data regarding differences in immunogenicity of varying coronavirus disease 2019 (COVID-19) mRNA vaccine regimens in CKD populations. Methods: We conducted a...
4.
Kitchlu A, Chan C, Jhaveri K, Delgado D, Tam P
Can J Kidney Health Dis
. 2023 Apr;
10:20543581231165711.
PMID: 37101848
Introduction And Objective: Amyloidoses are a heterogeneous group of disorders resulting from deposition of amyloid fibrils into extracellular tissues. While the kidneys are one of the most frequent sites of...
5.
Yau K, Enilama O, Levin A, Romney M, Singer J, Blake P, et al.
Can J Kidney Health Dis
. 2023 Mar;
10:20543581231160511.
PMID: 36950028
Background: People living with chronic kidney disease (CKD) have been disproportionately affected by the coronavirus disease 2019 (COVID-19) pandemic, including higher rates of infection, hospitalization, and death. Data on responsiveness...
6.
You J, Ploszaj L, Taskapan H, Sikaneta T, Ploszaj I, Joarder Z, et al.
Int Urol Nephrol
. 2023 Mar;
55(10):2621-2628.
PMID: 36940003
Background: The main barriers to arterio-venous fistula (AVF) utilization are primary failure, long maturation duration, and low secondary patency rates. Methods: In this retrospective cohort study, primary, secondary, functional primary,...
7.
Dixon S, Sontrop J, Al-Jaishi A, Killin L, McIntyre C, Anderson S, et al.
Can J Kidney Health Dis
. 2021 Sep;
8:20543581211041182.
PMID: 34471542
Background: Major Outcomes with Personalized Dialysate TEMPerature (MyTEMP) is a 4-year cluster-randomized clinical trial comparing the effect of using a personalized, temperature-reduced dialysate protocol versus a dialysate temperature of 36.5°C...
8.
Mederer T, Schmitteckert S, Volz J, Martinez C, Roth R, Thumberger T, et al.
PLoS Genet
. 2020 Nov;
16(11):e1009106.
PMID: 33151932
Hirschsprung disease (HSCR, OMIM 142623) involves congenital intestinal obstruction caused by dysfunction of neural crest cells and their progeny during enteric nervous system (ENS) development. HSCR is a multifactorial disorder;...
9.
Kitchlu A, Chan C, Leung N, Chen S, Latcha S, Tam P
Can J Kidney Health Dis
. 2020 Oct;
7:2054358120962589.
PMID: 33117547
Introduction And Objective: Onconephrology is a new and evolving field that deals with kidney complications in patients with cancer as well as the management of cancer in patients with preexisting...
10.
Davenport M, Pakarinen M, Tam P, Laje P, Holcomb 3rd G
J Pediatr Surg
. 2020 May;
55(5):785-788.
PMID: 32359916
No abstract available.